Maurice Hoffman

2.9k total citations
43 papers, 2.3k citations indexed

About

Maurice Hoffman is a scholar working on Pharmaceutical Science, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maurice Hoffman has authored 43 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmaceutical Science, 7 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maurice Hoffman's work include Advanced Drug Delivery Systems (16 papers), Drug Solubulity and Delivery Systems (14 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Maurice Hoffman is often cited by papers focused on Advanced Drug Delivery Systems (16 papers), Drug Solubulity and Delivery Systems (14 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Maurice Hoffman collaborates with scholars based in France, Germany and United Kingdom. Maurice Hoffman's co-authors include Philippe Maincent, Nathalie Ubrich, Alf Lamprecht, F. Kedzierewicz, Mary Perez, Claus‐Michael Lehr, Roland Bodmeier, Laurent Marchal‐Heussler, M Marchand-Arvier and Thomas Lecompte and has published in prestigious journals such as Circulation, Biomaterials and Journal of Controlled Release.

In The Last Decade

Maurice Hoffman

43 papers receiving 2.1k citations

Peers

Countries citing papers authored by Maurice Hoffman

Since Specialization

Citations

This map shows the geographic impact of Maurice Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurice Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurice Hoffman more than expected).

Fields of papers citing papers by Maurice Hoffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurice Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurice Hoffman. The network helps show where Maurice Hoffman may publish in the future.

Co-authorship network of co-authors of Maurice Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Maurice Hoffman. A scholar is included among the top collaborators of Maurice Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurice Hoffman. Maurice Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials 2021 ·BMJ ·Emily Herrett, Elizabeth Williamson, Kieran E. Brack, Danielle Beaumont, Alexander Perkins, Andrew Thayne, Haleema Shakur‐Still, Ian Roberts, Danielle Prowse, Ben Goldacre, Tjeerd van Staa, Thomas M. MacDonald, Jane Armitage, (unknown), P.A. Melrose, (unknown), (unknown), Michael Moore, Maurice Hoffman, Liam Smeeth	114
2	The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs 2021 ·Health Technology Assessment ·Emily Herrett, Elizabeth Williamson, Kieran E. Brack, Alexander Perkins, Andrew Thayne, Haleema Shakur‐Still, Ian Roberts, Danielle Prowse, Danielle Beaumont, Zahra Jamal, Ben Goldacre, Tjeerd van Staa, Thomas M. MacDonald, Jane Armitage, Michael Moore, Maurice Hoffman, Liam Smeeth	3
3	Frequent attendances at emergency departments in England 2020 ·Emergency Medicine Journal ·Geva Greenfield, Mitch Blair, Paul Aylin, Sonia Saxena, Azeem Majeed, Maurice Hoffman, Alex Bottle	15
4	Increase in the Vascular Residence Time of Propranolol-Loaded Nanoparticles Coated with Heparin 2008 ·Journal of Nanoscience and Nanotechnology ·M. Socha, Alf Lamprecht, (unknown), (unknown), Philippe Maincent, Jérôme Barré, Maurice Hoffman, Nathalie Ubrich	11
5	Effect of the microencapsulation of nanoparticles on the reduction of burst release 2007 ·International Journal of Pharmaceutics ·Abshar Hasan, M. Socha, Alf Lamprecht, (unknown), A. Sapin, Maurice Hoffman, Philippe Maincent, Nathalie Ubrich	144
6	Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles 2004 ·International Journal of Pharmaceutics ·Nathalie Ubrich, Christoph Schmidt, Roland Bodmeier, Maurice Hoffman, Philippe Maincent	68
7	Low Molecular Weight Heparin-Loaded Polymeric Nanoparticles: Formulation, Characterization, and Release Characteristics 2002 ·Drug Development and Industrial Pharmacy ·Valérie Hoffart, Nathalie Ubrich, (unknown), В. Н. Бабак, C. Vigneron, Maurice Hoffman, Thomas Lecompte, Philippe Maincent	71
8	Anticoagulant Activity of Heparin Following Oral Administration of Heparin‐Loaded Microparticles in Rabbits 2002 ·Journal of Pharmaceutical Sciences ·(unknown), Nathalie Ubrich, Valérie Hoffart, M Marchand-Arvier, Claude Vigneron, Maurice Hoffman, Philippe Maincent	35
9	Preparation and Characterization of Heparin-Loaded Polymeric Microparticles 2002 ·Drug Development and Industrial Pharmacy ·(unknown), Nathalie Ubrich, Valérie Hoffart, M Marchand-Arvier, C. Vigneron, Maurice Hoffman, Philippe Maincent	39
10	Preparation and In Vitro Evaluation of Heparin-Loaded Polymeric Nanoparticles 2001 ·Drug Delivery ·(unknown), Nathalie Ubrich, M Marchand-Arvier, C. Vigneron, Maurice Hoffman, Philippe Maincent	25
11	The preparation and evaluation of poly(ϵ-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug 2000 ·Journal of Controlled Release ·(unknown), (unknown), Alf Lamprecht, Nathalie Ubrich, A. Astier, Maurice Hoffman, Roland Bodmeier, Philippe Maincent	147
12	Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique 2000 ·International Journal of Pharmaceutics ·Alf Lamprecht, Nathalie Ubrich, Mary Perez, Claus‐Michael Lehr, Maurice Hoffman, Philippe Maincent	147
13	Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification 1999 ·International Journal of Pharmaceutics ·Alf Lamprecht, Nathalie Ubrich, Mary Perez, Claus‐Michael Lehr, Maurice Hoffman, Philippe Maincent	133
14	Comparison of the biodistribution in mice of 111indium oxine encapsulated into poly(lactic-co-glycolic(-D,L-85/15 and poly(epsilon caprolactone) nanocapsules 1999 ·Journal of Pharmaceutical Sciences ·Laurent Marchal‐Heussler, Pierre Thouvénot, Maurice Hoffman, Philippe Maincent	8
15	The antihypertensive effect of orally administered nifedipine‐loaded nanoparticles in spontaneously hypertensive rats 1997 ·British Journal of Pharmacology ·Young Tae Kim, (unknown), Maurice Hoffman, Isabelle Lartaud, Jeffrey Atkinson, (unknown)	49
16	Stability study of nanoparticles of poly(ɛ-caprolactone), poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) 1996 ·Biomaterials ·Dominique Lemoine, Camille François, F. Kedzierewicz, Véronique Préat, Maurice Hoffman, Philippe Maincent	182
17	Preparation and characterization of ethylcellulose microspheres containing 5-fluorouracil 1994 ·Journal of Microencapsulation ·(unknown), F. Kedzierewicz, Maurice Hoffman, Philippe Maincent	25
18	Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats 1992 ·Pharmaceutical Research ·Philippe Maincent, Pierre Thouvénot, C Amicabile, Maurice Hoffman, Jörg Kreuter, Patrick Couvreur, (unknown)	59
19	Haemodynamic effects of a new dihydropyridine calcium entry blocker, S‐12968‐(−), in a rat model of cardiovascular calcium overload 1992 ·British Journal of Pharmacology ·(unknown), Isabelle Lartaud, (unknown), Christine Capdeville‐Atkinson, Jean‐Marc Chillon, Maurice Hoffman, Jean‐Pierre Nicolas, Jeffrey Atkinson	1
20	The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blocker. 1991 ·Pharmaceutical Research ·(unknown), Jeffrey Atkinson, M. Guerret, Maurice Hoffman, (unknown), Philippe Maincent	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact